Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
General Dynamics
GD
$104B
| $21.7M | 0.03% |
105,438
-105,550
| -50% | -$21.2M |
|
|
ONCE
752
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $21.7M | 0.03% |
242,952
-292,679
| -55% | -$22.2M |
|
|
BMS
753
DELISTED
Bemis
BMS
| $21.6M | 0.03% |
474,299
+77,585
| +20% | +$3.46M |
|
754
Aecom
ACM
$8.36B
| $21.5M | 0.03% |
584,277
+533,649
| +1,054% | +$17.5M |
|
755
Ares Capital
ARCC
$14.4B
| $21.5M | 0.03% |
1,311,844
-126,276
| -9% | -$2.04M |
|
756
Nomad Foods
NOMD
$1.69B
| $21.4M | 0.03% |
1,471,435
+937,255
| +175% | +$13.7M |
|
757
Paylocity
PCTY
$8.09B
| $21.4M | 0.03% |
438,558
+223,689
| +104% | +$10.4M |
|
|
CHL
758
DELISTED
China Mobile Limited
CHL
| $21.4M | 0.03% |
423,313
-50,052
| -11% | -$2.67M |
|
759
Cal-Maine
CALM
$3.95B
| $21.4M | 0.03% |
520,720
-43,042
| -8% | -$1.61M |
|
760
Supernus Pharmaceuticals
SUPN
$2.62B
| $21.4M | 0.03% |
534,509
+525,974
| +6,163% | +$22.8M |
|
|
TEN
761
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $21.3M | 0.03% |
350,899
+221,114
| +170% | +$12.4M |
|
762
First Solar
FSLR
$22.4B
| $21.3M | 0.03% |
463,968
+381,893
| +465% | +$17.7M |
|
|
TFCFA
763
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $21.2M | 0.03% |
+803,914
| New | +$22.1M |
|
764
Jones Lang LaSalle
JLL
$17.8B
| $21.1M | 0.03% |
171,101
+59,494
| +53% | +$7.36M |
|
765
Healthpeak Properties
DOC
$14.9B
| $21.1M | 0.03% |
757,177
-339,592
| -31% | -$10.2M |
|
766
Steven Madden
SHOO
$3.36B
| $21M | 0.03% |
727,548
+315,285
| +76% | +$8.68M |
|
|
SAFE
767
Safehold
SAFE
$1.1B
| $21M | 0.03% |
365,634
+283,964
| +348% | +$16.3M |
|
768
Korn Ferry
KFY
$4.35B
| $20.9M | 0.03% |
530,707
+20,558
| +4% | +$709K |
|
769
Floor & Decor
FND
$5.84B
| $20.9M | 0.03% |
537,320
+526,481
| +4,857% | +$19.5M |
|
770
Rambus
RMBS
$9.44B
| $20.8M | 0.03% |
1,560,109
+628,799
| +68% | +$8.08M |
|
|
ENDP
771
DELISTED
Endo International plc
ENDP
| $20.8M | 0.03% |
2,429,062
+1,276,730
| +111% | +$12.3M |
|
772
Royal Bank of Canada
RY
$284B
| $20.8M | 0.03% |
+268,649
| New | +$20.1M |
|
773
Celanese
CE
$4.97B
| $20.7M | 0.03% |
198,580
-305,181
| -61% | -$30M |
|
|
HES
774
CALL
DELISTED
Hess
HES
| $20.7M | 0.03% |
440,900
| – | – |
|
775
Green Dot
GDOT
$765M
| $20.7M | 0.03% |
416,842
+372,444
| +839% | +$16.5M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.